Equinox Resources Limited (ASX:EQN)

Theseus Pharmaceuticals Statistics

Total Valuation

ASX:EQN has a market cap or net worth of AUD 12.59 million. The enterprise value is 10.50 million.

Market Cap	12.59M
Enterprise Value	10.50M

Important Dates

The next estimated earnings date is Monday, September 15, 2025.

Earnings Date	Sep 15, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:EQN has 155.43 million shares outstanding. The number of shares has increased by 20.54% in one year.

Current Share Class	155.43M
Shares Outstanding	155.43M
Shares Change (YoY)	+20.54%
Shares Change (QoQ)	+15.96%
Owned by Insiders (%)	17.79%
Owned by Institutions (%)	n/a
Float	82.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	209.61
PB Ratio	0.75
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.72
EV / Sales	174.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.96

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.01.

Current Ratio	2.56
Quick Ratio	2.36
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.38% and return on invested capital (ROIC) is -10.36%.

Return on Equity (ROE)	-17.38%
Return on Assets (ROA)	-9.95%
Return on Invested Capital (ROIC)	-10.36%
Return on Capital Employed (ROCE)	-16.07%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.58% in the last 52 weeks. The beta is 1.44, so ASX:EQN's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	-71.58%
50-Day Moving Average	0.08
200-Day Moving Average	0.11
Relative Strength Index (RSI)	49.40
Average Volume (20 Days)	134,797

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EQN had revenue of AUD 60,063 and -2.82 million in losses. Loss per share was -0.02.

Revenue	60,063
Gross Profit	23,376
Operating Income	-2.71M
Pretax Income	-2.82M
Net Income	-2.82M
EBITDA	-1.71M
EBIT	-2.71M
Loss Per Share	-0.02

Balance Sheet

The company has 2.21 million in cash and 122,445 in debt, giving a net cash position of 2.09 million or 0.01 per share.

Cash & Cash Equivalents	2.21M
Total Debt	122,445
Net Cash	2.09M
Net Cash Per Share	0.01
Equity (Book Value)	16.87M
Book Value Per Share	0.14
Working Capital	1.47M

Cash Flow

In the last 12 months, operating cash flow was -1.67 million and capital expenditures -3.69 million, giving a free cash flow of -5.36 million.

Operating Cash Flow	-1.67M
Capital Expenditures	-3.69M
Free Cash Flow	-5.36M
FCF Per Share	-0.03

Margins

Gross Margin	38.92%
Operating Margin	-4,513.87%
Pretax Margin	-4,697.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:EQN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.54%
Shareholder Yield	n/a
Earnings Yield	-22.41%
FCF Yield	-42.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:EQN has an Altman Z-Score of 17.5 and a Piotroski F-Score of 1.

Altman Z-Score	17.5
Piotroski F-Score	1